Medicare physician pay cut arrives before the new Congress can act
Democrats’ return to control of both chambers lands at an awkward moment for physicians: a Medicare physician fee schedule cut is already locked in for Jan. 1. CMS finalized a 2027 conversion factor of $32.63, down from $33.40, a 2.31% reduction for most physicians that exceeds the 1.68% cut the agency had proposed. For practices that participate in qualifying alternative payment models, the reduction is smaller at 1.83%, but it still tightens margins at a time when overhead, staffing costs, and payer friction remain relentless.
The payment cut arrives just as the one-time 2.5% increase Congress approved for 2026 expires on Dec. 31. In practical terms, the reversal eliminates a brief reprieve and returns physician reimbursement to a lower baseline without any built-in glide path. For small and independent practices, especially those with a high share of Medicare patients, the timing will shape hiring, capital investment, and access decisions long before lawmakers settle their next negotiation.
Congress must intervene to prevent further harm by immediately fixing cuts to the conversion factor.
A lame-duck fix is possible, but the odds are long
Any legislative rescue before Jan. 1 would have to come from the outgoing Republican-led Congress during a lame-duck session expected to focus on government funding and expiring health programs. Preventing the physician cuts remains a bipartisan priority, yet the calendar is unforgiving and the legislative agenda is crowded. Physician organizations are already pressing their case, but the path to a year-end fix runs through a narrow corridor of compromise.
The policy argument is straightforward. Medicare payment that lags the cost of delivering care pushes practices toward volume pressure, narrower participation in Medicare, or consolidation into larger systems that can absorb reimbursement shocks. A conversion factor that falls while inflation in labor, rent, supplies, and information technology continues to rise functions less like a technical adjustment and more like a structural squeeze on access.
The American College of Physicians is pushing for a longer-term answer.
“We need a permanent payment fix that will stabilize Medicare physician payments and protect access to care,” ACP President Jan Carney, MD, said in a Nov. 5 statement.
Coverage policy may matter more than partisan slogans for practice revenue
Democratic leaders have put two insurance-policy priorities near the top of their agenda: restoring enhanced ACA premium subsidies that expired at the end of 2025 and reversing the Medicaid cuts in HR 1. The Congressional Budget Office estimates that law will reduce federal Medicaid spending by about $911 billion from 2025 to 2034, while KFF projects 7.5 million more people will be uninsured. Medicaid work requirements begin Jan. 1 in most states.
For physicians, these numbers translate into payer mix, uncompensated care, and downstream utilization. When patients lose coverage, they delay primary care, postpone procedures, and present later with more advanced disease. Practices then absorb more missed visits, more self-pay friction, and a higher risk that preventive care will be replaced by episodic crisis management. In surgical and specialty settings, the strain is even sharper because delays can convert manageable disease into urgent intervention.
Dev GnanaDev, MD, chairman of the department of surgery at Arrowhead Regional Medical Center in Colton, Calif., said eliminating the Medicaid cuts and restoring the subsidies would ease financial strain on low- and lower-middle-income patients.
Veto power limits how far Democrats can go
The White House still matters more than congressional arithmetic. President Donald Trump retains veto power, and HR 1 stands as one of his signature legislative wins. He has signaled mixed intentions about how aggressively he would use that authority, but the veto remains a hard stop for any sweeping Democratic rewrite of federal health policy.
That constraint makes the next two years less about sweeping statutory change and more about leverage, oversight, and selective bargaining. Larry Levitt, executive vice president of KFF, said passing Democrats’ full agenda would be impossible with President Trump still in the White House. David Brueggeman, a managing director at Berkeley Research Group, said providers should not plan on relief coming from Washington.
The implication for physicians is blunt: even if committee chairs change, the executive branch can still block the kind of broad coverage reversal many practices want. Expect advocacy to shift toward narrower, politically survivable deals rather than a single comprehensive fix.
Prior authorization and Medicare Advantage are likely to face sharper scrutiny
Oversight may be the area where Democrats have the most immediate leverage. Prior authorization denials, Medicare Advantage practices, and the use of artificial intelligence in coverage determinations are all likely targets. Those issues already sit near the center of physician frustration, because they determine whether a patient can actually receive care after the clinician has made a recommendation.
Sen. Ron Wyden, D-Ore., who is expected to retake the Senate Finance Committee gavel, said insurers will be forced to answer to the committee once he is chair. For physicians, that could mean more hearings and more public pressure on payers, even if the legislative yield is modest. AI-driven utilization management is especially contentious because algorithmic opacity can turn a clinical appeal into a procedural maze with little visibility into how a denial was produced.
Consolidation, site-neutral payment, and the independent practice fight remain unsettled
Physicians remain divided on whether Democrats will embrace policies that would narrow hospital-payment advantages or accelerate site-neutral reimbursement. Krista Edelman, MD, a gastroenterologist and partner at Richmond (Va.) Gastroenterology Associates, said she hopes the election brings more scrutiny of healthcare consolidation, renewed attention to site-neutral payment, and policies that support independent physician ownership.
Dr. GnanaDev expects less movement. He said Democrats are unlikely to endorse site-neutral payment because they view hospitals’ EMTALA obligations as justification for higher reimbursement. The disagreement matters because site-based payment policy influences whether care migrates to higher-cost hospital outpatient departments or remains in community settings. Independent practices argue that uneven reimbursement accelerates acquisitions; hospitals counter that their obligations and infrastructure justify the difference.
Physicians in Congress are shifting toward the Democratic Party
About 20 physicians will serve in the 120th Congress, and for the first time in decades, Democrats outnumber Republicans among them. Pediatrician Annie Andrews, MD, D-S.C., and Abdul El-Sayed, MD, D-Mich., will be the first Democrats with medical degrees in the Senate since 1969. At the same time, the Senate is losing two Republican physicians: Sen. Roger Marshall, MD, R-Kan., lost his reelection bid, and Sen. Bill Cassidy, MD, R-La., the Senate health committee chair, is leaving after losing his primary.
Those changes do not guarantee policy alignment with organized medicine, but they do shift the internal language of Congress. Physician-legislators tend to frame reimbursement, access, and administrative burden in more operational terms than most nonclinical lawmakers, and that can influence how issues are prioritized in committee.
Workforce and telehealth bills are already waiting
Two bills have already drawn physician backing: the Resident Physician Shortage Act, which would add Medicare-funded residency slots, and the CONNECT for Health Act, which would make Medicare telehealth coverage permanent. Both speak to persistent structural problems rather than short-term politics. Graduate medical education capacity continues to trail demand in many specialties, while telehealth has become embedded in routine follow-up, chronic disease management, and access for patients with mobility or transportation barriers.
CMS will keep advancing regulations regardless of which party controls Congress. For physicians staring at the Jan. 1 cut, the immediate question is not whether Washington understands the problem. It is whether lawmakers can produce something durable before the payment downgrade becomes the new baseline.